Effectiveness of NESA in the Treatment of Cancer Survivors
NCT06230679
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Cancer Survivors
Interventions
DEVICE:
Non-invasive Neuromodulation
DEVICE:
Placebo Non-invasive Neuromodulation
Sponsor
Aníbal Báez Suárez